These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 3520340
1. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Bentley DL, Groudine M. Nature; ; 321(6071):702-6. PubMed ID: 3520340 [Abstract] [Full Text] [Related]
2. DNA repair in the MYC and FMS proto-oncogenes in ultraviolet light-irradiated human HL60 promyelocytic cells during differentiation. Islas AL, Hanawalt PC. Cancer Res; 1995 Jan 15; 55(2):336-41. PubMed ID: 7529133 [Abstract] [Full Text] [Related]
3. Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell lines. Arcinas M, Boxer LM. Oncogene; 1994 Sep 15; 9(9):2699-706. PubMed ID: 8058334 [Abstract] [Full Text] [Related]
5. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins. Ishida S, Shudo K, Takada S, Koike K. Cell Growth Differ; 1994 Mar 15; 5(3):287-94. PubMed ID: 8018561 [Abstract] [Full Text] [Related]
7. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO. Jiang G, Bi K, Tang T, Wang J, Zhang Y, Zhang W, Ren H, Bai H, Wang Y. Int Immunopharmacol; 2006 Jul 15; 6(7):1204-13. PubMed ID: 16714225 [Abstract] [Full Text] [Related]
8. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells. Ishida S, Shudo K, Takada S, Koike K. Cell Growth Differ; 1995 Mar 15; 6(3):229-37. PubMed ID: 7794791 [Abstract] [Full Text] [Related]
10. The HL60 cell line: a model system for studying human myeloid cell differentiation. Birnie GD. Br J Cancer Suppl; 1988 Dec 15; 9():41-5. PubMed ID: 3076064 [Abstract] [Full Text] [Related]
11. Changes in in vivo protein-DNA interactions occur at the c-myc P2 promoter during differentiation. Bryans M, Lang JC, Wilkie NM. Biochem Biophys Res Commun; 1993 Dec 30; 197(3):1363-9. PubMed ID: 8280153 [Abstract] [Full Text] [Related]
13. In situ and in vitro evidence for intragenic binding of nuclear factors at the murine c-myc locus. Tourkine N, Mechti N, Piechaczyk M, Jeanteur P, Blanchard JM. Oncogene; 1989 Aug 30; 4(8):973-8. PubMed ID: 2548146 [Abstract] [Full Text] [Related]
14. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters. Kohlhuber F, Strobl LJ, Eick D. Oncogene; 1993 Apr 30; 8(4):1099-102. PubMed ID: 8455938 [Abstract] [Full Text] [Related]
18. Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancer-binding protein epsilon, for up-regulation of PHGPx in HL60 cells stimulated with TNF alpha. Hattori H, Imai H, Kirai N, Furuhama K, Sato O, Konishi K, Nakagawa Y. Biochem J; 2007 Dec 01; 408(2):277-86. PubMed ID: 17688422 [Abstract] [Full Text] [Related]
20. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. Oncogene; 2002 May 13; 21(21):3414-21. PubMed ID: 12032779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]